May 5, 2011 – Women in the United States may now undergo mammography with a significantly lower radiation dose, with the U.S. Food and Drug Administration (FDA) clearance of the Sectra MicroDose Mammography system. The system uses photon-counting technology to reduce the radiation dose by half of that used by other digital or film-based systems.

“The advantages of a yearly mammography examination clearly outweigh the risks. But a woman undergoing regular mammography examinations is exposed to radiation every time she is screened, and so it is important to minimize radiation dose,” says Stamatia Destounis, M.D., managing partner, Elizabeth Wende Breast Care LLC.

Sectra MicroDose has already been contributing to a significant reduction of radiation dose in most major European mammography screening programs. It has been used for more than seven years and is operational in countries throughout Europe, Australia, New Zealand and Japan. Recently, the system was also approved in Canada and Russia.

“Until now, digital mammography systems have managed to reduce the radiation dose slightly below those of film-based systems,” said Dr. Jesper Söderqvist, president of Sectra’s mammography operations. “Sectra MicroDose enables mammography service providers to reduce the radiation dose by half, which is a significant benefit to women.”

Key to the very high image quality at significantly reduced radiation dose, is Sectra’s photon counting detector technology. Sectra MicroDose is the first imaging modality based on photon counting detector technology to receive FDA clearance.

Improving cancer detection with photon counting technology

Sectra MicroDose Mammography is based on the company’s proprietary photon counting technology. A multi-vendor comparison study presented at a European radiology congress in March 2011 indicates better cancer detection for Sectra MicroDose compared to other mammography systems available in the United States.

Unlike traditional analog and digital mammography modalities, which require a higher dose of radiation to ensure image quality. Sectra MicroDose Mammography detects X-ray photons individually. The detector makes it possible to reduce the radiation dose by half from that used by other digital or film based systems, while still obtaining as high or higher image quality. Images are delivered with 25 megapixles, which is two to four times higher resolution than that of other digital systems. The high resolution of the images aids detection of early changes that occur with breast cancer.

For more information: www.sectra.com


Related Content

News | Computed Tomography (CT)

July 23, 2026 — HOPPR has introduced HOPPR EF Chest CT Narrative Model, a foundation model that processes 3D chest CT ...

Time July 27, 2026
arrow
News | Breast Imaging

July 7, 2026 — QT Imaging Holdings, Inc. recently announced it has successfully completed its first routine inspection ...

Time July 07, 2026
arrow
News | MRI Breast

July 2, 2026 – Quibim has announced the European and UK launch of QP-Breast, its CE and UKCA-marked AI tool which ...

Time July 02, 2026
arrow
News | Mammography

June 30, 2026 — The Food and Drug Administration has cleared new contrast-enhanced mammography (CEM) and CEM biopsy ...

Time June 30, 2026
arrow
News | Mammography

June 23, 2026 — Using artificial intelligence (AI), researchers found that image-based risk scores for breast cancer ...

Time June 24, 2026
arrow
Feature | X-Ray | Kyle Hardner

Water-window X-rays allow researchers to visualize biological cells at high contrast without staining agents or other ...

Time June 23, 2026
arrow
News | Radiology Imaging

June 15, 2026 — Lead Glass Pro, a supplier of radiation shielding products, has expanded its turnkey installation ...

Time June 18, 2026
arrow
News | Digital Radiography (DR)

June 3, 2026 – Konica Minolta Healthcare Americas has announced a new version of AeroRemote Insights, the company’s ...

Time June 05, 2026
arrow
News | Women's Health

June 2, 2026 — Results of an American College of Radiology-managed retrospective study involving 110,000 women presented ...

Time June 02, 2026
arrow
News

May 21, 2026 – Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time May 22, 2026
arrow
Subscribe Now